Kitron signs a ten year agreement with DiaSorin's Irish branch

June 10, 2013 - Kitron announces that DiaSorin (FTSE MIB:DIA), through its Irish branch, has selected Kitron as electronics manufacturing partner for their Nucleic extraction instruments. The duration of the signed agreement is 10 years and will have an annual volume of more than NOK 10 million. The manufacturing of DiaSorin's instruments like the LIAISON® IXT will take place at Kitron's factory in Arendal, Norway and deliveries will take place from Q2 2013...

June 10, 2013 - Kitron announces that DiaSorin (FTSE MIB:DIA), through its Irish branch, has selected Kitron as electronics manufacturing partner for their Nucleic extraction instruments.

 

The duration of the signed agreement is 10 years and will have an annual volume of more than NOK 10 million. The manufacturing of DiaSorin's instruments like the LIAISON® IXT will take place at Kitron's factory in Arendal, Norway and deliveries will take place from Q2 2013.

 

Dag Songedal, Managing Director of Kitron AS declared: "Kitron is aiming to do business with the major players within our defined segments. DiaSorin is considered to be a global leading company within the In Vitro Diagnostics field. This cooperation will strengthen Kitron's position as one of Scandinavia's leading EMS companies."

 

Carlo Rosa, CEO of DiaSorin Group commented: "Kitron's expertise within EMS services including PCBAs, Box Build and High Level Assembly as well as their high ambition for world class quality, has been important for us when selecting a new partner".

  

About Kitron

It is one of Scandinavia's leading electronics manufacturing services companies for the Defense, Energy/Telecoms, Industry, Medical equipment and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, China and the United States. Kitron had revenues of about NOK 1.7 billion in 2012 and has about 1,200 employees. www.kitron.com

 

 

About DiaSorin

Headquartered in Italy and listed in the FTSE MIB Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. With their most recent acquisition of the NorDiag Group, DiaSorin gains access to the nucleic acid isolation and cell separation markets. Its line of products meets the clinical laboratory needs with flexibility in many clinical areas, such as infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market which identify DiaSorin Group as" the" in vitro diagnostics specialist. www.diasorin.com

 

For additional information, please contact:

Jørgen Bredesen, CEO of Kitron ASA

Tel. +47 48 25 25 84

E-mail [email protected]

 

Dag Songedal, Managing director of  Kitron AS

Tel. +47 91 38 64 68

E-mail [email protected]

Copyright Thomson Reuters


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: %s via Thomson Reuters ONE


[HUG#1708527]